144 related articles for article (PubMed ID: 37105848)
1. Association of KIR Genes Polymorphism and its HLA Ligands in Diffuse Large B-cell Lymphoma.
Daniela Maira C; Amanda Vansan M; Fernando G; Silvia M; Sofia L; Márcia D; Francisco José Penteado A; Jeane Eliete Laguila V; Cármino Antonio S
Clin Lymphoma Myeloma Leuk; 2023 Jun; 23(6):438-445. PubMed ID: 37105848
[TBL] [Abstract][Full Text] [Related]
2. Natural killer cell killer immunoglobulin-like gene receptor polymorphisms in non-Hodgkin lymphoma: possible association with clinical course.
Pamuk GE; Tozkir H; Uyanik MS; Gurkan H; Duymaz J; Pamuk ON
Leuk Lymphoma; 2015; 56(10):2902-7. PubMed ID: 25699652
[TBL] [Abstract][Full Text] [Related]
3. Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases.
De Re V; Caggiari L; De Zorzi M; Repetto O; Zignego AL; Izzo F; Tornesello ML; Buonaguro FM; Mangia A; Sansonno D; Racanelli V; De Vita S; Pioltelli P; Vaccher E; Berretta M; Mazzaro C; Libra M; Gini A; Zucchetto A; Cannizzaro R; De Paoli P
PLoS One; 2015; 10(2):e0117420. PubMed ID: 25700262
[TBL] [Abstract][Full Text] [Related]
4. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
[TBL] [Abstract][Full Text] [Related]
5. Genetic profile of KIR and HLA in southern Chinese Han population.
Zhen J; Wang D; He L; Zou H; Xu Y; Gao S; Yang B; Deng Z
Hum Immunol; 2014 Jan; 75(1):59-64. PubMed ID: 24055695
[TBL] [Abstract][Full Text] [Related]
6. Genetic profiles of killer-cell immunoglobulin-like receptors and HLA ligands in Thai blood donors.
Kitpoka P; Tammakorn C; Chaisri S; Leelayuwat C; Mongkolsuk T; Thammanichanond D
Hum Immunol; 2016 Jun; 77(6):470-5. PubMed ID: 27131859
[TBL] [Abstract][Full Text] [Related]
7. Genetic diversity of the KIR/HLA system and outcome of patients with metastatic colorectal cancer treated with chemotherapy.
De Re V; Caggiari L; De Zorzi M; Talamini R; Racanelli V; D' Andrea M; Buonadonna A; Zagonel V; Cecchin E; Innocenti F; Toffoli G
PLoS One; 2014; 9(1):e84940. PubMed ID: 24497922
[TBL] [Abstract][Full Text] [Related]
8. Donor KIR B Genotype Improves Progression-Free Survival of Non-Hodgkin Lymphoma Patients Receiving Unrelated Donor Transplantation.
Bachanova V; Weisdorf DJ; Wang T; Marsh SGE; Trachtenberg E; Haagenson MD; Spellman SR; Ladner M; Guethlein LA; Parham P; Miller JS; Cooley SA
Biol Blood Marrow Transplant; 2016 Sep; 22(9):1602-1607. PubMed ID: 27220262
[TBL] [Abstract][Full Text] [Related]
9. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A
Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
[TBL] [Abstract][Full Text] [Related]
10. KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.
Venstrom JM; Zheng J; Noor N; Danis KE; Yeh AW; Cheung IY; Dupont B; O'Reilly RJ; Cheung NK; Hsu KC
Clin Cancer Res; 2009 Dec; 15(23):7330-4. PubMed ID: 19934297
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of killer immunoglobulin-like receptors (KIRs) and HLA ligands in northeastern Thais.
Chaisri S; Kitcharoen K; Romphruk AV; Romphruk A; Witt CS; Leelayuwat C
Immunogenetics; 2013 Sep; 65(9):645-53. PubMed ID: 23812166
[TBL] [Abstract][Full Text] [Related]
12. KIR genes and HLA class I ligands in a Caucasian Brazilian population with colorectal cancer.
Portela P; Merzoni J; Lindenau JD; Damin DC; Wilson TJ; Roesler R; Schwartsmann G; Jobim LF; Jobim M
Hum Immunol; 2017 Mar; 78(3):263-268. PubMed ID: 28088355
[TBL] [Abstract][Full Text] [Related]
13. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
14. Killer cell immunoglobulin-like receptors in Thai patients with leukemia and diffuse large B-cell lymphoma.
Vejbaesya S; Sae-Tam P; Khuhapinant A; Srinak D
Hum Immunol; 2014 Jul; 75(7):673-6. PubMed ID: 24755352
[TBL] [Abstract][Full Text] [Related]
15. Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell response.
Makanga DR; Jullien M; David G; Legrand N; Willem C; Dubreuil L; Walencik A; Touzeau C; Gastinne T; Tessoulin B; Le Gouill S; Mahé B; Gagne K; Chevallier P; Clemenceau B; Retière C
Oncoimmunology; 2021 Jun; 10(1):1936392. PubMed ID: 34178429
[TBL] [Abstract][Full Text] [Related]
16. The Influence of HLA and KIR Genes on Malignant Melanoma Development and Progression.
Kandilarova SM; Paschen A; Mihaylova A; Ivanova M; Schadendorf D; Naumova E
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):73-81. PubMed ID: 28083606
[TBL] [Abstract][Full Text] [Related]
17. [Association of genetic polymorphisms of KIR-HLA system with chronic myeloid leukemia among ethnic Hans from southern China].
Deng Z; Zhen J; Wang D; He L; Zou H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Feb; 34(1):53-57. PubMed ID: 28186594
[TBL] [Abstract][Full Text] [Related]
18. HLA variations in patients with diffuse large B-cell lymphoma and association with disease risk and prognosis: a case-control study.
Diamanti I; Fylaktou A; Verrou E; Vlachaki E; Sinakos M; Katodritou E; Ouranos K; Minti F; Gioula G
Front Genet; 2024; 15():1341822. PubMed ID: 38680423
[TBL] [Abstract][Full Text] [Related]
19. Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation.
Symons HJ; Leffell MS; Rossiter ND; Zahurak M; Jones RJ; Fuchs EJ
Biol Blood Marrow Transplant; 2010 Apr; 16(4):533-42. PubMed ID: 19961944
[TBL] [Abstract][Full Text] [Related]
20. KIR, HLA, and IL28B variant predict response to antiviral therapy in genotype 1 chronic hepatitis C patients in Japan.
Nozawa Y; Umemura T; Joshita S; Katsuyama Y; Shibata S; Kimura T; Morita S; Komatsu M; Matsumoto A; Tanaka E; Ota M
PLoS One; 2013; 8(12):e83381. PubMed ID: 24349500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]